NASDAQ · FMED

Fidelity Disruptive Medicine ETF (FMED)

$32.45+0.75%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$32.45▲ 31.69% in range
Sep 29, 2025Low $23.55 · High $32.89Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

Fidelity Disruptive Medicine ETF closed at $32.45 on Sep 28, up 0.75%, 1.3% below its 52-week closing high. Volume of 6.1K shares was 0.87× its 20-day average (close to normal).

Split-adjusted performance: -0.1% over one month, +37.3% over six months, +34.3% over one year.

Short interest was 4.1K shares at the Sep 15 settlement, down 36.9% from the prior report (1.0 days to cover).

Market cap$51.9M1.6M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yieldNone$0.112 last paid
52-week range23.55 – 32.89−1.3% from high
Volume6.1K0.87× 20-day avg
Volatility · 60d24.6%Annualised
Short % of float—1.0 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W +1.6%1M −0.1%3M +13.8%6M +37.3%YTD +20.0%1Y +34.3%3Y +46.3%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short4.1K−36.9% vs prior
Days to cover1.0Settled Sep 15
% of float—
Short vol. 10d40.4%of daily volume

News about Fidelity Disruptive Medicine ETF

All news →

No recent articles focused on Fidelity Disruptive Medicine ETF.

Quick answers

What is FMED's market cap?
$51.91M, based on the Sep 28 close of $32.45.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology